FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for tolterodine tartrate filed by Mylan Pharmaceuticals Inc. under NDA 020771.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Tolterodine tartrate (Tolterodine tartrate)

Snippet

SUPPL AP for TOLTERODINE TARTRATE (TOLTERODINE TARTRATE)